Kirian specialises in intellectual property and regulatory affairs, with a particular focus on food, pharmaceuticals and life sciences. His IP work includes complex patent litigation, often involving cross-border issues, and support and advice in respect of IP portfolio management. His regulatory work spans the fields of clinical trials, launch and marketing strategies, pricing and reimbursement, tendering and life-cycle management.

Education
Kirian obtained a Master in Law degree magna cum laude at the Universiteit Gent. After three years of IP practice, Kirian acquired additional international experience through postgraduate studies (LL.M) at the University of California, Berkeley School of Law, where he also obtained the Law and Technology Certificate.

• Belgian Parliament has adopted urgent 2026 healthcare budget measures: what's the impact on the pharma industry?

  By Kirian Claeye, Bart Junior Bollen |January 2026

• EU Reaches Pharma Package Deal: Key Changes at a Glance

  By Kirian Claeye, Bart Junior Bollen, Lora Arifagic |December 2025

• Belgian Constitutional Court strikes down pharma industry 'unavailability contribution'

  By Kirian Claeye, Bart Junior Bollen |November 2025